TechNavio today launched its report Global Biopharmaceuticals Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the significant trends impacting this market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said; ”The Global Biopharmaceuticals market provides several growth opportunities for vendors because of the increasing demand for biopharmaceuticals across the globe. As a result, vendors in the market are investing heavily in the RandD of novel biologic components and to improve their efficacy in the treatment of different diseases. Similarly, vendors are increasingly investing in the RandD of effective drugs for the treatment of hepatitis C.”
According to the report, Monoclonal Antibodies is one of the major segments in the Global Biopharmaceuticals market. There is an increase in the use of monoclonal antibodies in various therapies such as radio-immunotherapy, antibody-directed enzyme prodrug therapy, and the formulation of biopharmaceutical drugs for the treatment of different diseases such as cancer, rheumatoid arthritis, multiple sclerosis, and ulcerative colitis. As a result, this has increased the revenue generation in the market.
Further, the report discusses that the patent expiry of top-selling drugs poses a challenge to the growth of the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players.
TechNavio, the market research platform of Infiniti Research Ltd, publishes periodic reports on niche and emerging technologies. For further information, please visit https://www.technavio.com/content/global-biopharmaceuticals-market-2011-2015
http://goo.gl/xwnrJ
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Report – Global Biopharmaceuticals Market 2011-2015
